278 related articles for article (PubMed ID: 17956732)
1. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.
Carbia-Nagashima A; Gerez J; Perez-Castro C; Paez-Pereda M; Silberstein S; Stalla GK; Holsboer F; Arzt E
Cell; 2007 Oct; 131(2):309-23. PubMed ID: 17956732
[TBL] [Abstract][Full Text] [Related]
2. Role of RSUME in inflammation and cancer.
Antico Arciuch VG; Tedesco L; Fuertes M; Arzt E
FEBS Lett; 2015 Nov; 589(22):3330-5. PubMed ID: 26297826
[TBL] [Abstract][Full Text] [Related]
3. In silico structural and functional characterization of the RSUME splice variants.
Gerez J; Fuertes M; Tedesco L; Silberstein S; Sevlever G; Paez-Pereda M; Holsboer F; Turjanski AG; Arzt E
PLoS One; 2013; 8(2):e57795. PubMed ID: 23469069
[TBL] [Abstract][Full Text] [Related]
4. Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes.
Fuertes M; Elguero B; Gonilski-Pacin D; Herbstein F; Rosmino J; Ciancio Del Giudice N; Fiz M; Falcucci L; Arzt E
Front Endocrinol (Lausanne); 2022; 13():864780. PubMed ID: 35528020
[TBL] [Abstract][Full Text] [Related]
5. Relationship between RSUME and HIF-1α/VEGF-A with invasion of pituitary adenoma.
He W; Huang L; Shen X; Yang Y; Wang D; Yang Y; Zhu X
Gene; 2017 Mar; 603():54-60. PubMed ID: 27989771
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.
Berta MA; Mazure N; Hattab M; Pouysségur J; Brahimi-Horn MC
Biochem Biophys Res Commun; 2007 Aug; 360(3):646-52. PubMed ID: 17610843
[TBL] [Abstract][Full Text] [Related]
7. RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.
Wu Y; Tedesco L; Lucia K; Schlitter AM; Garcia JM; Esposito I; Auernhammer CJ; Theodoropoulou M; Arzt E; Renner U; Stalla GK
Oncotarget; 2016 Sep; 7(36):57878-57893. PubMed ID: 27506944
[TBL] [Abstract][Full Text] [Related]
8. RWD Domain as an E2 (Ubc9)-Interaction Module.
Alontaga AY; Ambaye ND; Li YJ; Vega R; Chen CH; Bzymek KP; Williams JC; Hu W; Chen Y
J Biol Chem; 2015 Jul; 290(27):16550-9. PubMed ID: 25918163
[TBL] [Abstract][Full Text] [Related]
9. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
10. RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity.
Druker J; Liberman AC; Antunica-Noguerol M; Gerez J; Paez-Pereda M; Rein T; Iñiguez-Lluhí JA; Holsboer F; Arzt E
Mol Cell Biol; 2013 Jun; 33(11):2116-27. PubMed ID: 23508108
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.
Salahuddin S; Fath EK; Biel N; Ray A; Moss CR; Patel A; Patel S; Hilding L; Varn M; Ross T; Cramblet WT; Lowrey A; Pagano JS; Shackelford J; Bentz GL
Sci Rep; 2019 Jan; 9(1):208. PubMed ID: 30659232
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen.
Chachami G; Stankovic-Valentin N; Karagiota A; Basagianni A; Plessmann U; Urlaub H; Melchior F; Simos G
Mol Cell Proteomics; 2019 Jun; 18(6):1197-1209. PubMed ID: 30926672
[TBL] [Abstract][Full Text] [Related]
13. RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.
Shan B; Gerez J; Haedo M; Fuertes M; Theodoropoulou M; Buchfelder M; Losa M; Stalla GK; Arzt E; Renner U
Endocr Relat Cancer; 2012 Feb; 19(1):13-27. PubMed ID: 22009797
[TBL] [Abstract][Full Text] [Related]
14. PHD3-SUMO conjugation represses HIF1 transcriptional activity independently of PHD3 catalytic activity.
Núñez-O'Mara A; Gerpe-Pita A; Pozo S; Carlevaris O; Urzelai B; Lopitz-Otsoa F; Rodríguez MS; Berra E
J Cell Sci; 2015 Jan; 128(1):40-9. PubMed ID: 25380826
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation indirectly suppresses activity of the HIF-1α pathway in intestinal epithelial cells.
Malkov MI; Flood D; Taylor CT
J Biol Chem; 2023 Nov; 299(11):105280. PubMed ID: 37742924
[TBL] [Abstract][Full Text] [Related]
16. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
17. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
18. Heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity.
Aillet F; Lopitz-Otsoa F; Egaña I; Hjerpe R; Fraser P; Hay RT; Rodriguez MS; Lang V
PLoS One; 2012; 7(12):e51672. PubMed ID: 23284737
[TBL] [Abstract][Full Text] [Related]
19. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
[TBL] [Abstract][Full Text] [Related]
20. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
Kim ET; Kim KK; Matunis MJ; Ahn JH
Biochem Biophys Res Commun; 2009 Oct; 388(1):41-5. PubMed ID: 19635459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
